As consumer interest in holistic wellness continues to grow, mood, stress, and sleep are increasingly viewed as interconnected health priorities.

In this podcast, Ava Ghobadpour MS, RD, business development manager, U.S./Canada, Pharmactive, discusses the evolving saffron market and the science behind the company’s proprietary Affron saffron extract, which is distributed by Saanroo in the U.S.

Ghobadpour explains why clinically validated botanical ingredients are gaining traction as consumers seek gentle, everyday solutions that support emotional well-being.

Affron stands out from conventional saffron extracts due to its standardized bioactive compounds, clinically studied dosing, and portfolio of 13 human clinical trials spanning adolescents to menopausal women.

The conversation also explores the importance of quality assurance in the saffron supply chain. Because saffron is among the world’s most valuable botanicals, adulteration remains a significant concern.

Ghobadpour outlines Pharmactive’s sourcing practices, proprietary extraction process, DNA testing, and full traceability system designed to ensure ingredient authenticity and consistency.

Topics discussed:

• Consumer demand for integrated mood, stress, and sleep support
• The clinical research behind Affron saffron extract
• Standardization, dosing, and formulation versatility
• Human clinical studies across multiple populations
• Saffron supply chain challenges and adulteration risks
• DNA testing, traceability, and quality assurance
• The role of clinically validated botanicals in product innovation